BackgroundCheck.run
Search For

Peter M Kanter, 75925 Quaker Rd, East Aurora, NY 14052

Known as:
Peter Dr Kanter Peter M Kantor Peter M Kanster

Peter Kanter Phones & Addresses

925 Quaker Rd, East Aurora, NY 14052    508-7596369   

Lake Luzerne, NY   

Hudson Falls, NY   

Hamburg, NY   

Aurora, NY   

Plymouth, MA   

Washingtonvle, NY   

Warren, NY   

925 Quaker Rd, East Aurora, NY 14052   

Get Report
Control this profile

Mentions for Peter M Kanter

Career records & work history

License Records

Peter Kanter

Address:
East Aurora, NY
Licenses:
License #: 5009 - Expired
Issued Date: Aug 10, 1999
Expiration Date: Feb 28, 2017
Type: Veterinarian

Peter Kanter resumes & CV records

Resumes

Peter Kanter Photo 20

Sole Proprietor Of Practice

Location:
East Aurora, NY
Industry:
Pharmaceuticals
Work:

Sole Proprietor of Practice
Peter Kanter Photo 21

Peter Kanter

Peter Kanter Photo 22

Peter Kanter

Publications & IP owners

Us Patents

Method For Using Chlorin And Bacteriochlorin-Based Aminophenyl Dtpa And Nsconjugates For Mr Contrast Media And Radiopharmaceuticals

US Patent:
7078014, Jul 18, 2006
Filed:
Mar 17, 2003
Appl. No.:
10/390438
Inventors:
Ravindra K. Pandey - Williamsville NY, US
Zachary Grossman - Buffalo NY, US
Peter Kanter - East Aurora NY, US
Thomas J. Dougherty - Grand Island NY, US
Assignee:
Health Research, Inc. - Buffalo NY
International Classification:
A61B 5/055
US Classification:
424 93, 424 111, 424 165, 424 91, 540145
Abstract:
A method for MR imaging that comprises conducting the MR imaging after injecting compositions that are chemical combination of porphyrins, chlorins, bacteriochlorins, and related tetra-pyrrolic compounds with radioactive elements such as Technetium, Gadolinium, Indiumand radioactive iodine. When the element can form cations, the compound is usually a chelate with the porphyrin or chlorin structure. When the element forms anions, the compound is usually a direct chemical combination of the radioactive element into the porphyrin or chlorin structure. The method uses the compounds of the invention for diagnostic imaging of hyperproliferative tissue such as tumors and new blood vessel growth as is associated with the wet form of age related macular degeneration and methods of making the compounds. Compounds for MRI contrast imaging of the invention are usually Tc, Inor Gd(III) complexes of compounds of the formula:.

Chlorin And Bacteriochlorin-Based Difunctional Aminophenyl Dtpa And Nsconjugates For Mr Contrast Media And Radiopharmaceuticals

US Patent:
7097826, Aug 29, 2006
Filed:
Jun 21, 2002
Appl. No.:
10/177129
Inventors:
Ravindra K. Pandey - Williamsville NY, US
Zachary Grossman - Buffalo NY, US
Peter Kanter - East Aurora NY, US
Thomas J. Dougherty - Grand Island NY, US
Assignee:
Health Research, Inc. - Buffalo NY
International Classification:
A61B 5/055
US Classification:
424 9362, 424 111, 424 91, 424 165, 424 93, 424 9361, 534 14, 540145
Abstract:
A compound comprising a chemical combination of a photodynamic tetra-pyrrolic compound with a plurality of radionuclide element atoms such that the compound may be used to enhance MR imaging and also be used as a photodynamic compound for use in photodynamic therapy to treat hyperproliferative tissue. The preferred compounds have the structural formula:.

Method Of Reducing Alopecia And Bladder Toxicity Of Cyclophosphamide

US Patent:
7534818, May 19, 2009
Filed:
Sep 15, 2003
Appl. No.:
10/663109
Inventors:
Youcef M. Rustum - Amherst NY, US
Shousong Cao - East Amherst NY, US
Farukh Durrani - Snyder NY, US
Karoly Toth - North Amherst NY, US
Peter Kanter - East Aurora NY, US
Harry Slocum - Kenmore NY, US
Assignee:
Health Research, Inc. - Buffalo NY
International Classification:
A01N 59/02
US Classification:
514561, 514706
Abstract:
The present invention discloses a method for reducing alopecia and bladder toxicity associated with the anti-cancer agent cyclophosphamide. The method comprises administering to an individual, in need of such a treatment, cyclophosphamide and a selenium compound. The selenium compounds may be administered before, during or after administration of the anti-cancer agent.

Multi Dtpa Conjugated Tetrapyrollic Compounds For Phototherapeutic Contrast Agents

US Patent:
7897140, Mar 1, 2011
Filed:
Jun 30, 2006
Appl. No.:
11/479524
Inventors:
Ravindra K. Pandey - Williamsville NY, US
Lalit Goswami - Amherst NY, US
Joseph Spernyak - West Seneca NY, US
Peter Kanter - East Aurora NY, US
Richard Mazurchuk - Clarence Center NY, US
Assignee:
Health Research, Inc. - Buffalo NY
International Classification:
A61K 5/055
US Classification:
424 9362, 424 93, 424 936, 424 9361, 424 9363, 424 9364, 424 9365, 424 165, 424 111, 424 91, 540121
Abstract:
Novel tetrapyrollic water soluble photosensitizing and imaging compounds and the methods of treating and imaging hyperproliferative tissue, e. g. tumors and hypervacularized tissue such as found in macular degeneration. Broadly, the compounds are tetrapyrollic photosensitizer compounds where the tetrapyrollic compound is a chlorin, bacteriochlorin, porphyrin, pyropheophorbide, purpurinimide, or bacteriopurpurinimide having 3 to 6 —CHCONHphenylCHCH(N(CHCOOH)))(CHN(CHCOOH)(CHCHN(CHCOOH))) groups or esters thereof or complexes thereof with gadolinium(III).

Chlorin And Bacteriochlorin-Based Difunctional Aminophenyl Dtpa And Nsconjugates For Mr Contrast Media And Radiopharmaceuticals

US Patent:
8133473, Mar 13, 2012
Filed:
May 10, 2006
Appl. No.:
11/431275
Inventors:
Ravindra K. Pandey - Williamsville NY, US
Zachary Grossman - Buffalo NY, US
Peter Kanter - East Aurora NY, US
Thomas J. Dougherty - Grand Island NY, US
Assignee:
Health Research, Inc. - Buffalo NY
International Classification:
A61B 5/055
US Classification:
424 9362, 424 111, 424 165, 424 91, 424 93, 540145
Abstract:
A compound comprising a chemical combination of a photodynamic tetra-pyrrolic compound with a plurality of radionuclide element atoms such that the compound may be used to enhance MR imaging and also be used as a photodynamic compound for use in photodynamic therapy to treat hyperproliferative tissue. The preferred compounds have the structural formula:.

Chlorin And Bacteriochlorin-Based Aminophenyl Dtpa And N2S2 Conjugates For Mr Contrast Media And Radiopharmaceuticals

US Patent:
2001004, Nov 29, 2001
Filed:
Dec 18, 2000
Appl. No.:
09/739155
Inventors:
Ravindra Pandey - Williamsville NY, US
Zachary Grossman - Buffalo NY, US
Peter Kanter - East Aurora NY, US
Thomas Dougherty - Grand Island NY, US
International Classification:
A61B005/055
C07F005/00
A61K031/555
US Classification:
514/185000, 424/009362, 534/014000, 534/015000, 540/145000
Abstract:
Compositions that are chemical combination of porphyrins, chlorins, bacteriochlorins, and related tetra-pyrrolic compounds with radioactive elements such as Technetium, Gadolinium, Indiumand radioactive iodine. When the element can form cations, the compound is usually a chelate with the porphyrin or chlorin structure. When the element forms anions, the compound is usually a direct chemical combination of the radioactive element into the porphyrin or chlorin structure. The invention further includes the method of using the compounds of the invention for diagnostic imaging of hyperproliferative tissue such as tumors and new blood vessel growth as is associated with the wet form of age related macular degeneration and methods of making the compounds. Compounds for MRI contrast imaging of the invention are usually Tc, Inor Gd(III) complexes of compounds of the formula:

Possible Relatives

David B Kanter  Daniel C Kanter  Douglas A Kanter  Earl B Kanter  Edna Kanter  Elaine Y Kanter  Peter L Johnson  Peter J Stan  Peter Stanczak 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.